Literature DB >> 17503507

DBH -1021C-->T does not modify risk or age at onset in Parkinson's disease.

Lani S Chun1, Ali Samii, Carolyn M Hutter, Alida Griffith, John W Roberts, Berta C Leis, Anthony D Mosley, P Luke Wander, Karen L Edwards, Haydeh Payami, Cyrus P Zabetian.   

Abstract

DBH is a candidate gene in Parkinson's disease (PD) and contains a putative functional polymorphism (-1021C-->T) that has been reported to modify PD susceptibility. We examined -1021C-->T in a sample of 1,244 PD patients and 1,186 unrelated control subjects. There was no significant difference in allele (p = 0.14) or genotype (p = 0.26) frequencies between the two groups. A similar result was obtained after pooling our data with those previously published. Furthermore, we found no evidence for an effect of genotype on age at onset among patients. Our findings argue against DBH -1021C-->T as a risk factor or age at onset modifier in PD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17503507      PMCID: PMC2823266          DOI: 10.1002/ana.21149

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  17 in total

1.  Establishment of genetic associations for complex diseases is independent of early study findings.

Authors:  Thomas A Trikalinos; Evangelia E Ntzani; Despina G Contopoulos-Ioannidis; John P A Ioannidis
Journal:  Eur J Hum Genet       Date:  2004-09       Impact factor: 4.246

2.  The effects of human population structure on large genetic association studies.

Authors:  Jonathan Marchini; Lon R Cardon; Michael S Phillips; Peter Donnelly
Journal:  Nat Genet       Date:  2004-03-28       Impact factor: 38.330

Review 3.  Commentary: grading the credibility of molecular evidence for complex diseases.

Authors:  John P A Ioannidis
Journal:  Int J Epidemiol       Date:  2006-03-15       Impact factor: 7.196

Review 4.  Neuropathology of Parkinson's disease.

Authors:  L S Forno
Journal:  J Neuropathol Exp Neurol       Date:  1996-03       Impact factor: 3.685

Review 5.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

Authors:  W R Gibb; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

Review 6.  The role of the locus coeruleus in the development of Parkinson's disease.

Authors:  M Gesi; P Soldani; F S Giorgi; A Santinami; I Bonaccorsi; F Fornai
Journal:  Neurosci Biobehav Rev       Date:  2000-08       Impact factor: 8.989

7.  A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: evidence for a major functional polymorphism at the DBH locus.

Authors:  C P Zabetian; G M Anderson; S G Buxbaum; R C Elston; H Ichinose; T Nagatsu; K S Kim; C H Kim; R T Malison; J Gelernter; J F Cubells
Journal:  Am J Hum Genet       Date:  2001-01-19       Impact factor: 11.025

8.  Locus coeruleus lesions potentiate neurotoxic effects of MPTP in dopaminergic neurons of the substantia nigra.

Authors:  G Bing; Y Zhang; Y Watanabe; B S McEwen; E A Stone
Journal:  Brain Res       Date:  1994-12-30       Impact factor: 3.252

9.  Effects of locus coeruleus lesions on parkinsonian signs, striatal dopamine and substantia nigra cell loss after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in monkeys: a possible role for the locus coeruleus in the progression of Parkinson's disease.

Authors:  M Mavridis; A D Degryse; A J Lategan; M R Marien; F C Colpaert
Journal:  Neuroscience       Date:  1991       Impact factor: 3.590

10.  Serum dopamine- -hydroxylase: decrease after chemical sympathectomy.

Authors:  R Weinshilboum; J Axelrod
Journal:  Science       Date:  1971-09-03       Impact factor: 47.728

View more
  5 in total

1.  Dopamine beta-hydroxylase -1021C>T association and Parkinson's disease.

Authors:  Owen A Ross; Michael G Heckman; Alexandra I Soto; Nancy N Diehl; Kristoffer Haugarvoll; Carles Vilariño-Güell; Jan O Aasly; Sigrid Sando; J Mark Gibson; Timothy Lynch; Anna Krygowska-Wajs; Grzegorz Opala; Maria Barcikowska; Krzysztof Czyzewski; Ryan J Uitti; Zbigniew K Wszolek; Matthew J Farrer
Journal:  Parkinsonism Relat Disord       Date:  2008-08-22       Impact factor: 4.891

2.  Association of the rs1611115 polymorphism in DBH gene with Parkinson's disease: a meta-analysis.

Authors:  Shan Kang; Mingxia Bi; Xixun Du; Qian Jiao; Hong Jiang
Journal:  Neurol Sci       Date:  2018-09-05       Impact factor: 3.307

3.  Association of Dopamine Beta-Hydroxylase (DBH) Polymorphisms with Susceptibility to Parkinson's Disease.

Authors:  Peng Shao; Yun-Xia Yu; Jing-Xi Bao
Journal:  Med Sci Monit       Date:  2016-05-13

4.  Genomic, transcriptomic, and metabolomic profiles of hiPSC-derived dopamine neurons from clinically discordant brothers with identical PRKN deletions.

Authors:  Holly N Cukier; Hyunjin Kim; Anthony J Griswold; Simona G Codreanu; Lisa M Prince; Stacy D Sherrod; John A McLean; Derek M Dykxhoorn; Kevin C Ess; Peter Hedera; Aaron B Bowman; M Diana Neely
Journal:  NPJ Parkinsons Dis       Date:  2022-06-29

5.  Association Analyses of SNAP25, HNMT, FCHSD1, and DBH Single-Nucleotide Polymorphisms with Parkinson's Disease in a Northern Chinese Population.

Authors:  Cuiyun Dai; Yichi Zhang; Xiaoni Zhan; Meihui Tian; Hao Pang
Journal:  Neuropsychiatr Dis Treat       Date:  2021-05-27       Impact factor: 2.570

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.